Firm

Monica Sánchez of Becerril, Coca & Becerril explains how the Mexican intellectual property framework, including compulsory licences and the Bolar clause, works alongside emerging technologies to balance pharmaceutical innovation with public health access

Xiaoping Wu of Wanhuida Intellectual Property explains how the CNIPA’s recent invalidation of a sustained-release patent illustrates key considerations in assessing inventive step for pharmaceutical formulation patents

Join Managing IP and CAS on December 11 for a practical discussion on why critical references are still missed in intellectual property searches, and how strategic search design can reduce risk and improve outcomes

Masato Iida of Shiga International Patent Office says the decision by the Grand Panel of the Intellectual Property High Court provides a practical benchmark for calculating damages in cosmetic and medical patent infringement cases

Alex Levkin of iPNOTE draws on his experience as a patent attorney to offer a personal account of how AI can streamline cross-border intellectual property filings and address the time and money trade-off

María Aurora García of Berken IP explains how Argentina’s evolving non-use cancellation system strengthens trademark integrity, streamlines registration, and promotes fairer market competition through efficient, partial, and administrative cancellation mechanisms